Fontaine et al., 2006 - Google Patents
Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosisFontaine et al., 2006
- Document ID
- 1268076076019709157
- Author
- Fontaine M
- Baird G
- Connor K
- Rudge K
- Sales J
- Donachie W
- Publication year
- Publication venue
- Vaccine
External Links
Snippet
Using a virulent United Kingdom Corynebacterium pseudotuberculosis isolate, an ovine experimental model of caseous lymphadenitis was developed, in which the manifestation of disease was equivalent to the naturally observed infection in this country. Subsequently, the …
- 241000186225 Corynebacterium pseudotuberculosis 0 title abstract description 103
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fontaine et al. | Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis | |
| Simionatto et al. | Mycoplasma hyopneumoniae: from disease to vaccine development | |
| RU2735101C2 (en) | Vaccine composition against infection caused by streptococcus suis | |
| JP2022078317A (en) | Composition for immunizing against staphylococcus aureus | |
| US9180170B2 (en) | Brucella abortus proteins and methods of use thereof | |
| Wunder et al. | A live attenuated-vaccine model confers cross-protective immunity against different species of the Leptospira genus | |
| Fu et al. | Immunogenicity and protective efficacy of recombinant Haemophilus parasuis SH0165 putative outer membrane proteins | |
| Uchiyama et al. | Prevalence of Met-203 type spaA variant in Erysipelothrix rhusiopathiae isolates and the efficacy of swine erysipelas vaccines in Japan | |
| CA3133182A1 (en) | Bacterial vaccine components from staphylococcus aureus and uses thereof | |
| Ellis et al. | Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model) | |
| US20160228528A1 (en) | A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine | |
| Ozberk et al. | Contribution of cryptic epitopes in designing a group A streptococcal vaccine | |
| US20160074497A1 (en) | Staphylococcus live cell vaccines | |
| US20190105382A1 (en) | Compositions and methods of preparing leptospira | |
| Lo et al. | Characterization of two lipoproteins in Pasteurella multocida | |
| Héchard et al. | Evaluation of protection against Chlamydophila abortus challenge after DNA immunization with the major outer-membrane protein-encoding gene in pregnant and non-pregnant mice | |
| Wang et al. | Three novel immunogenic proteins determined through 2-Dimensional electrophoresis and mass spectrometry with immune serum confer protection against challenge with porcine Pasteurella multocida in mouse models | |
| Wang et al. | Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae | |
| US20220288183A1 (en) | Vaccine constructs and uses thereof against staphylococcus infections | |
| US20210283234A1 (en) | Engineered salmonella serovar typhimurium strains, compositions thereof, and methods of use | |
| Wunder Jr et al. | A Live Attenuated Vaccine Model Confers Cross-Protective Immunity Against Different Species of Leptospira spp. | |
| Flahou et al. | Protective immunization with homologous and heterologous antigens against Helicobacter suis challenge in a mouse model | |
| Selim et al. | Evaluation of protective efficacy of mixed PLD toxoid and clostridial vaccines against caseous lymphadenitis (CLA) in small ruminants at Egypt | |
| AU2023213843A1 (en) | Vaccine against leptospirosis | |
| BRPI1106737A2 (en) | LEPTOSPIRA SPP LEMA PROTEIN. FOR USE AS IMMUNIOBIOLOGICAL |